Cannara Biotech Inc. (LOVE.V) TSXV

1.83

-0.06(-3.17%)

Updated at February 20 03:59PM

Currency In CAD

Valuation

Market Cap168.12M
Enterprise Value195.34M
P/E Ratio14.52
PEG Ratio-1.02
Price/Sales Ratio1.56
Price/Book Ratio1.54
Enterprise/Revenue1.72
Enterprise/EBITDA7.16

Fiscal Year

Fiscal YearAugust 31, 2025
Most Recent QuarterNovember 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.14

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue107.32M
Revenue/Share1.2
Gross Profit47.22M
EBITDA28.18M
Net Income13.08M
Diluted EPS0.14

Balance Sheet

Total Cash16.52M
Total Cash/Share0.18
Total Debt34.85M
Total Debt/Equity0.31
Current Ratio2.7
Book Value Per Share1.19

Price History

52-Week Change41.86
52-Week High2.07
52-Week Low1.06
Moving Average 50 Days1.8
Moving Average 200 Days1.66

Statistics

Average Volume56,368
Shares Outstanding95.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateFebruary 13, 2023